Literature DB >> 23280021

A comparison between the reference values of MRI and EUS and their usefulness to surgeons in rectal cancer.

J Yimei1, Z Ren, X Lu, Z Huan.   

Abstract

BACKGROUND: For these patients with colorectal cancers, improving their quality of life is just as important as clearing them of their tumor burden. AIM: To assess the reference value to surgeons of magnetic resonance imaging (MRI) and endorectal ultrasound (EUS) in local staging of rectal cancer. PATIENTS AND METHODS: According to the criteria we set, 69 patients received MRI and 60 patients received EUS, all by senior doctors. We compared two groups in staging accuracy of depth of penetration (T), lymph nodes positive (N) and combined T and N (TN) result. Strategy one (Str1.) was chosen based on MRI or EUS staging. Strategy two (Str2.) took into account clinical parameters, such as computed tomography (CT) and colonoscopy. Strategy three (Str3.) was the best treatment strategy; this was, in part, based on analysis of patients' specimen pathological results. Compared to Str.1 and Str.2, the use of Str.3 as the reference standard separately reflected the reference values of MRI and EUS for surgeons and actual treatment accuracy.
RESULTS: EUS had higher sensitivity in T1 (p = 0.044 < 0.05) and specificity in T2 (p = 0.039 < 0.05) than MRI. MRI had higher sensitivity in N staging (p = 0.046 < 0.05) and was more accurate in pT1~4N1~2 (p < 0.05) than EUS. Reference values for surgery (comparing appropriate rates of Str.1 with Str.3) of MRI and EUS were 79.7% vs. 76. 7%, respectively (p > 0.05). The actual treatment accuracy (comparing appropriate rates of Str.2 with Str.3) was increased up to 94.2% vs. 91.7%, respectively (p > 0.05).
CONCLUSIONS: EUS is good for early-stage patients but MRI for local advanced ones. Strategies both could be improved by combining clinical factors that lead to similar reference values for surgery.

Entities:  

Mesh:

Year:  2012        PMID: 23280021

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer.

Authors:  Pietro Marone; Mario de Bellis; Valentina D'Angelo; Paolo Delrio; Valentina Passananti; Elena Di Girolamo; Giovanni Battista Rossi; Daniela Rega; Maura Claire Tracey; Alfonso Mario Tempesta
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

Review 2.  Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging.

Authors:  Tyler J Fraum; Joseph W Owen; Kathryn J Fowler
Journal:  Clin Colon Rectal Surg       Date:  2016-09

3.  Comparison of Changes in Disease-Free and Overall Survival of Resectable Rectal Adenocarcinoma between 2010 and 2015.

Authors:  Justas Žilinskas; Mantas Jokubauskas; Giedrė Smailytė; Irina Gineikienė; Algimantas Tamelis
Journal:  Visc Med       Date:  2019-06-12

4.  How Useful Is Endoscopic Ultrasound in Differentiating T3/T4a T Stage of Colorectal Cancer: A Prospective Study.

Authors:  Chaoqun Han; Xuelian Tang; Ming Yang; Kun Zhang; Jun Liu; Rong Lin; Zhen Ding
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

5.  Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.

Authors:  Erman Aytaç; Leyla Özer; Bilgi Baca; Emre Balık; Yersu Kapran; Orhun Cığ Taşkın; Başak Oyan Uluç; Mehmet Ufuk Abacıoğlu; Murat Gönenç; Yasemin Bölükbaşı; Barbaros E Çil; Bülent Baran; Cem Aygün; Mehmet Erdem Yıldız; Kemal Ünal; Burçak Erkol; Tunç Yaltı; Uğur Özbek; Tan Attila; Nurdan Tözün; Bengi Gürses; Sibel Erdamar; Özlem Er; Nuran Beşe; Orhan Bilge; Güralp Onur Ceyhan; Nil Molinas Mandel; Uğur Selek; Cengiz Yakıcıer; Hülya Kayserili Karabey; Murat Saruç; Volkan Özben; Eren Esen; Emre Özoran; Erkan Vardareli; Levent Güner; İsmail Hamzaoğlu; Dursun Buğra; Tayfun Karahasanoğlu; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

6.  Evidence-based treatment of patients with rectal cancer.

Authors:  Qiang Zhang; Jie Yang; Qun Qian
Journal:  Oncol Lett       Date:  2016-01-12       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.